Grant Fernau

Grant Fernau is an accomplished sales professional specializing in rare diseases and orphan drugs, currently serving as a Strategic Account Manager at Crinetics Pharmaceuticals since July 2025. Prior roles include Strategic Account Liaison and Key Account Manager at Chiesi Group, where responsible for sales of Myalept and MyCapssa across multiple states. Fernau previously worked as a Rare Disease Specialist at Amryt Pharma, a Specialty Account Manager at Horizon, and held managerial positions within Takeda and Amgen, achieving significant recognition. Early career experience includes vaccine sales at Sanofi Pasteur and teaching golf at The Players Club at Deer Creek. Fernau holds dual Bachelor’s degrees in Broadcast Journalism from the University of Nebraska-Lincoln.